Ariane Elizabeth Erickson

Title: Ariane Elizabeth Erickson: Innovator in Electrophoresis Technology

Introduction

Ariane Elizabeth Erickson is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of electrophoresis, particularly in the detection of diseases through innovative methodologies. With a total of 2 patents to her name, her work is paving the way for advancements in medical diagnostics.

Latest Patents

One of Ariane's latest patents focuses on using electrophoresis for disease detection based on controlled molecular charge. This method utilizes electrophoresis to identify the presence of a target compound in a patient sample by analyzing the charge state of the compound and a label. The charge state correlates to the total net charge of a binder conjugated to the compound. The labeled bound complex is applied to an electrophoresis substrate, where an electric potential is introduced. This causes the labeled bound complex to migrate toward the electrode with the opposite charge, forming a migration pattern over time. The presence of the compound is identified based on the labeled bound complex band and the migration pattern or velocity.

Career Highlights

Ariane is currently employed at Hemex Health, Inc., where she continues to develop her innovative ideas and technologies. Her work is instrumental in enhancing the capabilities of disease detection methods, making them more efficient and reliable.

Collaborations

Ariane collaborates with notable colleagues, including Peter M Galen and David Richard Bell. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Ariane Elizabeth Erickson is a trailblazer in the realm of electrophoresis technology, with her innovative patents significantly impacting disease detection methodologies. Her contributions are vital to the future of medical diagnostics and healthcare.